[Myelodysplastic syndromes (MDS) and their evolution]

Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis.

ESMO open·2022

Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinib.

ESMO open·2021

A validation study of combined resection and ablation therapy for multiple hepatocellular carcinoma.

Clinical radiology·2021

Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinoma.

ESMO open·2021

First Detection of Photons with Energy beyond 100 TeV from an Astrophysical Source.

Physical review letters·2019

Differences in background characteristics of patients with chronic hepatitis C who achieved sustained virologic response with interferon-free versus interferon-based therapy and the risk of developing hepatocellular carcinoma after eradication of hepatitis C virus in Japan.

Journal of viral hepatitis·2016

[Balancing efficacy and cost in multiple myeloma immunotherapy: rethinking treatment strategies from a sustainability perspective].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Current state and key challenges of immune and cell therapy for multiple myeloma in Japan].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Diagnosis and management of bleeding disorders caused by hyperfibrinolysis (designated intractable disease No. 347 in Japan)].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Atypical hemolytic uremic syndrome: key points in differential diagnosis and recent advances in treatment].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Updates on antiphospholipid syndrome].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Current diagnosis and treatment of congenital platelet function disorders: focus on Glanzmann thrombasthenia and Bernard-Soulier syndrome].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

Melasma Flaring and Unmasking After Treatment With a 1,927-nm Non-ablative Fractional Thulium Fiber Laser.

Cureus·2026

From Dermographism in Bracelets to Dermatophytosis in Circles: The First Case of Tinea Imbricata Diagnosed in Morocco.

Cureus·2026

Analytical validation of a multiplex PCR assay for differentiation of five clinically significant nontuberculous mycobacterial species.

Frontiers in microbiology·2026

Treatment patterns and outcomes in patients with multiple myeloma in second relapse in Colombia (freedomm): a multicenter observational study.

Frontiers in oncology·2026

Mesenteric defect closure versus non-closure after complete mesocolic excision in minimally invasive right colectomy: a retrospective study.

International journal of colorectal disease·2026

Applying the Moving Epidemic Method to Emergency Department Syndromic Surveillance to identify the Start of Influenza Seasons in New South Wales, Australia.

Influenza and other respiratory viruses·2026

Related Experiment Videos

[Myelodysplastic syndromes (MDS) and their evolution]

Related Concept Videos

Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis.

Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinib.

A validation study of combined resection and ablation therapy for multiple hepatocellular carcinoma.

Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinoma.

First Detection of Photons with Energy beyond 100 TeV from an Astrophysical Source.

Differences in background characteristics of patients with chronic hepatitis C who achieved sustained virologic response with interferon-free versus interferon-based therapy and the risk of developing hepatocellular carcinoma after eradication of hepatitis C virus in Japan.

[Balancing efficacy and cost in multiple myeloma immunotherapy: rethinking treatment strategies from a sustainability perspective].

[Current state and key challenges of immune and cell therapy for multiple myeloma in Japan].

[Diagnosis and management of bleeding disorders caused by hyperfibrinolysis (designated intractable disease No. 347 in Japan)].

[Atypical hemolytic uremic syndrome: key points in differential diagnosis and recent advances in treatment].

[Updates on antiphospholipid syndrome].

[Current diagnosis and treatment of congenital platelet function disorders: focus on Glanzmann thrombasthenia and Bernard-Soulier syndrome].

Melasma Flaring and Unmasking After Treatment With a 1,927-nm Non-ablative Fractional Thulium Fiber Laser.

From Dermographism in Bracelets to Dermatophytosis in Circles: The First Case of Tinea Imbricata Diagnosed in Morocco.

Analytical validation of a multiplex PCR assay for differentiation of five clinically significant nontuberculous mycobacterial species.

Treatment patterns and outcomes in patients with multiple myeloma in second relapse in Colombia (freedomm): a multicenter observational study.

Mesenteric defect closure versus non-closure after complete mesocolic excision in minimally invasive right colectomy: a retrospective study.

Applying the Moving Epidemic Method to Emergency Department Syndromic Surveillance to identify the Start of Influenza Seasons in New South Wales, Australia.

Related Experiment Videos

[Myelodysplastic syndromes (MDS) and their evolution]

Related Concept Videos

Related Articles